The urgency of constructing a method for evaluating the clinical efficacy of traditional Chinese medicine and a three-integrated review system:thoughts on the clinical study of Zhongfeng Xingnao oral prescription for the treatment of acute cerebral hemorrhage published in LancetXU Jia-xin, WANG Jian-xin, YU Zong-liang, GAO Rui785-789
Comparison of innovative drug approvals in China and the United States in 2023GAN Chang-jiao, YUAN Yan-fang, ZHENG Yang, YANG Yue, FANG Jun790-796
Research on the history and effect of incentive policy for pediatric drug development in ChinaHUANG Jian, YANG Yong, LU Xin, XIAN Xue-guo, YAO Zheng-rong797-803
Comparison of application procedures and expedited programs of advanced therapy medical products in China and the United StatesYIN Hui-fang, LI Xiao-fen, QIN Xiao-yan, SU Yi-gang, FAN Jie, FAN Yi811-822
Review on analytical methods for host cell proteins of antibody drugs based on MSXU Xuan, SHENG Ning, ZHANG Jin-lan823-828
Research progress in organoantimony-bismuth complexes in antitumor therapyXIE Wu-xing, LIU Yong-ping, LEI Jian, CHEN Yi829-836
Applications of benchtop NMR in drug analysisPU Heng-ting, LI Jie, ZHANG Na, YU Li-ju, LIU Yang837-842
Quality evaluation and bioequivalence study of posaconazole enteric-coated tabletsWANG Hua-wei, SUI Xin, WU Xiu-jun, CAO Ying, CHEN Lu, LI Xiao-bin, LI Mei-ye, GE Yu-xin, WANG Wen-ping843-849
Study on dissolution curves and permeation rates of rivaroxaban reference tablets from different sourcesMA Ling-yun, WANG Lu-nan, MENG Yu-xin, ZHANG Guang-chao, LIU Qian, NIU Jian-zhao, SUN Hui-min850-856